Enlivex Therapeutics
ENLV
ENLV
11 hedge funds and large institutions have $3.36M invested in Enlivex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
63% less call options, than puts
Call options by funds: $300K | Put options by funds: $801K
Holders
11
Holding in Top 10
–
Calls
$300K
Puts
$801K
Top Buyers
| 1 | +$264K | |
| 2 | +$103K | |
| 3 | +$91K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$26K |
| 5 |
Morgan Stanley
New York
|
+$24K |